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Abstract
Generalized linear models, such as logistic regression, are widely used to model the associa-
tion between a treatment and a binary outcome as a function of baseline covariates. However, it
is hard to interpret the coefficients of a logistic regression model as these are log odds ratios. For
example, it is hard to compare coefficients from different studies, even if treatment is random-
ized, since odds ratios are not collapsible. Coefficients from Poisson regressions are measures
of multiplicative treatment effects and hence are collapsible. However, with a binary outcome
the parameters in a Poisson regression are variation dependent, which can be undesirable for
modeling, estimation and computation. Focusing on the special case where the treatment is
also binary, Richardson et al. (2017) propose a novel binomial regression model, that allows
direct modeling of the relative risk. The model uses a log odds-product nuisance model leading
to variation independent parameter spaces. Building on this we present general approaches to
modeling the multiplicative effect of a categorical or continuous treatment on a binary outcome.
A Monte Carlo simulation demonstrates the superior performance of our proposed methods. A
data analysis further exemplifies our methods on real data.
Keywords: Binomial Regression Model; Generalized Odds Product; Multiplicative Treatment
Effect.
1 Introduction
The logistic model is widely used to model binary outcomes, such as alive versus dead, yes versus no,
success versus failure, and so on. In a logistic model, the probability of the outcome Y is modeled
as a function of covariates using a logit function. The coefficient associated with a particular binary
covariate, which we will refer to as treatment, is a log-odds ratio. Here the odds is simply the ratio
between the probability of Y = 1 and the probability of Y = 0, and an odds ratio is the ratio
between the odds for two different levels of treatment. The convexity of the likelihood makes it
feasible to compute maximum likelihood estimates for large data sets.
However, there are several limitations of logistic regression. Importantly, When it comes to
interpreting coefficients, odds ratios are not always intuitive and scientists rarely ask for them
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(Lumley et al., 2006). Furthermore, the odds ratio is not collapsible, which means the marginal odds
ratio will not lie in the convex hull of stratum-specific odds ratios (Greenland et al., 1999). Instead,
in epidemiological and other studies, researchers are often more interested in estimating treatment
effects on the multiplicative scale. These can be formulated as a series of relative risks, which are
ratios contrasting the probability of Y = 1 in treatment group Z = z versus the probability of
Y = 1 in a baseline group Z = z0:
rr(z0, z) =
pr(Y = 1 | Z = z)
pr(Y = 1 | Z = z0) .
In this paper, we consider ordinal or continuous treatment Z.
Within the generalized linear model framework, multiplicative treatment effects are typically
modeled via a Poisson regression which imposes a linear association between the log of the prob-
ability of Y = 1 and covariates. However, Poisson regression with a binary outcome has draw-
backs in terms of modeling, prediction and computation. This is because rr(z0, z) is variation
dependent on the baseline probability pr(Y = 1 | Z = z0). For example, if rr(z0, z) = 2, then
pr(Y = 1 | Z = z) = 2 × pr(Y = 1 | Z = z0), so that pr(Y = 1 | Z = z0) ≤ 0.5. Therefore there
is a restricted domain over which the quantities ({rr(z0, z); z},pr(Y = 1 | Z = z0)) are compatible
with a valid probability distribution. This may lead to misspecification when modeling. Also the
fitted probability for any treatment given covariates can go outside of the range [0, 1].
For the special case of binary treatment, Richardson et al. (2017) provide a simple alternative
to modeling the relative risk. In addition to specifying a model for log(rr), they propose a nuisance
model for the log of the odds product (op):
op(z0, z) =
pr(Y = 1 | Z = z)pr(Y = 1 | Z = z0)
{1− pr(Y = 1 | Z = z)}{1− pr(Y = 1 | Z = z0)} .
This leads to an unrestricted domain for which the quantities ({rr(z0, z); z},op(z0, z)) are compat-
ible with a valid probability distribution. However, their method is restricted to binary treatments.
Building on Richardson et al. (2017), we present two new approaches that model multiplicative
effects with continuous or categorical treatments. The first imposes an assumption that the relative
risk is a monotone function of an ordinal treatment. The second introduces a new nuisance model,
using a so-called generalized odds product, that is variation independent of the relative risks.
2 Methodology
2.1 Parameterization with Monotonic Treatment Effects
Denote the relative risk between a treatment z and the baseline treatment z0 given a random vector
of covariates v as
rr(z0, z; v) =
pr(Y = 1 | V = v, Z = z)
pr(Y = 1 | V = v, Z = z0) , (1)
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where Z can be a continuous or categorical treatment. For notational simplicity, we denote pr(Y =
1 | Z = z, V = v) as pz(v). Similarly, the odds product of treatment z and baseline treatment z0 is
op(z0, z; v) =
p0(v)pz(v)
{1− p0(v)}{1− pz(v)} . (2)
To fix ideas, first consider the special case where Z is a continuous treatment taking values in
a bounded interval, say [0, 1]. Our goal is to find φ(v) so that for any v, the mapping given by
(log{rr(0, z; v)}, z ∈ [0, 1];φ(v))→ (pz(v), z ∈ [0, 1])
is a diffeomorphism between the interior of their domains. Recall that Richardson et al. (2017) show
that if we let φ(v) = log{op(0, 1; v)}, then any possible value of (log{rr(0, 1; v)}, φ(v)) implies that
(p0(v), p1(v)) ∈ (0, 1)2. The key insight for our development is that if log rr(0, z; v) is monotonic
in z, or equivalently, the treatment effect is monotonic for all covariate values v, then pz(v) is also
monotonic in z. Consequently,
0 < min{p0(v), p1(v)} ≤ pz(v) ≤ max{p0(v), p1(v)} < 1 (z ∈ [0, 1]).
Therefore, any possible value of (log rr(0, z; v), φ(v)) such that log(rr(0, z; v)) is monotone in z
implies that pz(v) ∈ (0, 1) for all z ∈ [0, 1].
The monotonic treatment effect assumption we have invoked may be considered reasonable in
many real-life situations. For example, the recovery probability in the arm receiving full-dosage is
usually at least as high as in the small-dosage arm (Yang et al., 2003; Al-Mamgani et al., 2008;
Lang and Birkenmeier, 2015), and greater income may be associated with a higher probability of
satisfaction (Easterlin, 2001; Ball and Chernova, 2008).
This idea above can be generalized to accommodate more types of variables for the treatment
Z, such as ordinal and unbounded continuous variables.
Theorem 1 (Variation independence with monotonic treatment effects). Let Z ⊆ R and V be
the support of Z and V , respectively. Let h(z, v) and g(v) be real-valued functions with support
Z ×V and V, respectively. If h(z, v) is bounded and monotonic in z, then there exists a unique set
of proper probability distributions {pz(v); z ∈ Z, v ∈ V} such that log{rr(z0, z; v)} = h(z, v) and
log{op(zinf , zsup; v)} = g(v), where zinf = inf{z : z ∈ Z}, zsup = sup{z : z ∈ Z} and
op(zinf , zsup; v) = lim
z1→zinf
lim
z2→zsup
pz1(v)pz2(v)
(1− pz1(v))(1− pz2(v))
.
Remark 1. The boundedness condition on h(v, z) guarantees that the implied probabilities pz(v)
are bounded away from 0.
In our simulations and data analysis, we consider a bounded treatment Z and the following
models for log{rr(z0, z; v)} and log{op(zmin, zmax; v)}:
log{rr(z0, z;V, γ)} = γTV (z − z0) z ∈ Z, (3)
log{op(zmin, zmax;V, β)} = βTV, (4)
where zmin = min{z : z ∈ Z}, zmax = max{z : z ∈ Z}. In light of the boundedness condition on
h(v, z), when the treatment is unbounded, researchers should avoid specifying a linear model such
as the one on the right hand side of (3).
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The log-likelihood for a unit i can be written as
l(γ, β|zi, vi, yi) = yi log{pzi(vi; γ, β)}+ (1− yi) log{1− pzi(vi; γ, β)}. (5)
Inference on γ and β can be obtained in standard fashion. We provide explicit formula for Wald-
type confidence intervals in the supplementary materials.
We finish this part with a remark that the proposed assumption of monotonic treatment effects
may be falsified from the observed data. In practice, analysts may use descriptive plots to examine
the relationship between the treatment and outcome, and use them to assess plausibility of the
monotonic treatment effect assumption. See Section 4 for an illustration.
2.2 Parameterization with a categorical treatment
The approach introduced in Section 2.1 is not directly applicable if the relative risk is not monotonic
in z. We now consider a categorical treatment whose effect on the outcome is not necessarily
monotonic. Suppose that the treatment Z takes values in {z0, . . . , zK}, where z0 is chosen as the
baseline treatment. The quantities of interest are relative risks rr(z0, zk; v) (k = 1, . . . ,K). For
notational simplicity, we denote pr(Y = 1 | Z = zk, V = v) as pk(v), and rr(z0, zk; v) as rr(0, k; v).
Following Wang et al. (2017), we introduce a nuisance model on the generalized odds product
gop(v) =
K∏
k=0
pk(v)
1− pk(v) . (6)
The following theorem states that the generalized odds product is variation independent of the set
of relative risks.
Theorem 2 (Variation independence with a categorical treatment). Let M denote a (K + 1)-
dimensional model on
rr(0, k; v) =
pk(v)
p0(v)
(k = 1, . . . ,K),
gop(v) =
K∏
k=0
pk(v)
1− pk(v) .
For any v, the map given by
(p0(v), . . . , pK(v))→ (logrr(0, 1; v), . . . , logrr(0,K; v), loggop(v)) (7)
is a diffeomorphism from (0, 1)K+1 to (R)K+1. Furthermore, the models in M are variation inde-
pendent of each other.
The proof of Theorem 2 is deferred to the supplementary materials. In our simulations and
data analysis, we consider the following specifications of M:
log{rr(0, k; v)} = αTkX (k = 1, . . . ,K), (8)
log{gop(v)} = βTW, (9)
where X = X(v), W = W (v). Theorem 2 shows that the parameters α1, . . . , αK , and β are
variation independent so that their domains are unconstrained. Maximum likelihood estimates and
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associated inference for parameters α1, . . . , αK , and β can then be obtained in standard fashion.The
relative risk model in this approach is more flexible than the corresponding model (3) in Section
2.1, which assumes monotonicity, thus (8) has K-times as many parameters.
3 Simulation
3.1 Simulation with Monotonic Treatment Effects
We evaluate the finite sample performance of our proposed methods. We generate the treatment
Z from a uniform distribution on {0, 1, 2}. The covariates V include an intercept and a random
variable generated from a uniform distribution on the interval [−2, 2]. We generate Y from models
(3) and (4), where γ = (0, 1)T, β = (−0.5, 1)T. All simulation results are based on 1000 Monte-Carlo
runs.
Table 1 summarizes the simulation results. The bias of our estimator is small when the sample
size is 100, and further decreases as the sample size increases. Similarly with the standard deviation
accuracy, defined as the ratio of estimated standard deviation and Monte Carlo standard deviation.
The coverage probability of the Wald-type confidence interval also achieves the nominal 95%
coverage-rate in all scenarios considered here.
Table 1: Monte Carlo simulation results based on 1000 runs for
the proposed estimator which assumes monotonic treatment effects.
The true values of γ0 and γ1 are 0 and 1, respectively
Sample Size 100 500 1000
Bias(SE)
γ0 0.002(0.022) −0.001(0.004) 0.000(0.002)
γ1 0.090(0.025) 0.013(0.004) 0.006(0.002)
SD Accuracy
γ0 1.022 1.040 0.994
γ1 1.109 1.032 1.018
Coverage
γ0 0.950 0.949 0.948
γ1 0.949 0.950 0.958
SE, standard error.
SD Accuracy = estimated standard deviation / Monte Carlo standard de-
viation.
Nominal level = 95%.
3.2 Simulation with a categorical treatment
We conduct a similar set of simulations as in 3.1, except that Y is generated following models (8)
and (9), where α1 = (−0.5, 1)T, α2 = (0.5, 1.5)T, β = (1,−0.5)T. As theory predicts, the bias of
5
our point and variance estimators goes to zero as sample size increases. Although at sample size
100, the estimated standard deviation and the coverage rate of α1 are biased upwards, the bias
decreases as sample size becomes larger.
Table 2: Monte Carlo simulation results based on 1000 runs for the relative risk model with a generalized
odds product nuisance model. The true values for vectors α1 and α2 are (−0.5, 1)T and (0.5, 1.5)T
respectively
Sample Size 100 500 1000
α1 α2 α1 α2 α1 α2
Bias(SE)
−0.069(0.056) 0.038(0.033) −0.016(0.009) 0.002(0.006) −0.002(0.004) 0.004(0.003)
0.078(0.055) 0.162(0.045) 0.011(0.009) 0.023(0.007) 0.009(0.004) 0.013(0.004)
SD Accuracy
1.307 1.019 0.993 1.000 1.036 1.014
1.421 1.023 1.037 1.037 1.033 1.033
Coverage
0.975 0.954 0.951 0.948 0.964 0.957
0.973 0.972 0.956 0.961 0.956 0.955
SE, standard error.
SD Accuracy = estimated standard deviation / Monte Carlo standard deviation.
Nominal level = 95%.
4 Application to Titanic Data
We illustrate the use of our proposed methods in Section 2 by studying the association between the
passenger class and death in the tragic sinking of the Titanic in 1912. We compare the results from
our proposed models with those obtained from generalized linear models. The data set consists of
1309 passengers from three passenger classes, of whom 809 lost their lives during the event. For
illustration we removed the 263 (20.1%) passengers for whom age was missing, resulting in a sample
size of 1046, including 284 (27.1%) passengers in the first class, 261 (25.0%) in the second class, and
501 (47.9%) in the third class. A sensitivity analysis imputing the missing ages provides similar
results. The empirical probability of death is lowest in the first class at 36.3%, increasing to 55.9%
in the second class, and 73.9% in the third class. Given this, we initially consider modeling the
relative risk of death as a monotone function of passenger class, using the first class as the baseline.
Figure 1 shows the survival statuses of passengers by their passenger class, age and sex. Female
passengers tend to have lower probability of death compared to males, and children tend to have
lower probability of death compared to adults. These observations suggest that the relative risk of
death with respect to passenger class may vary with sex and age. We let the covariates X and W
be identical, which include age, sex, age squared, and the interaction between age and sex.
We apply four different models to estimate the variation in the relative risk of death stratifying
on age and sex: 1) Poisson regression; 2) Logistic regression; 3) Monotone: the model given by (3)
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Figure 1: Passengers’ survival statuses by passenger class, age, and sex. The number of passengers
in each group is shown in the center of the corresponding plot.
and (4); 4) GOP: the model given by (8) and (9). Results for models 1) and 2) were obtained using
the glm function in R via maximum likelihood with robust standard errors. Table 3 shows regression
Table 3: Coefficient estimates via different models.
2nd 2nd* 2nd* 2nd* 2nd* 3rd 3rd* 3rd* 3rd* 3rd*
male age/10 age2/ male* male age/10 age2/ male*
100 age/10 100 age/10
Point Estimate
Monotone 1.891 −1.543 −0.165 0.011 0.058 3.782 −3.086 −0.329 0.022 0.116
GOP −1.134 1.439 0.780 −0.033 −0.617 2.204 −1.212 0.053 0.020 −0.309
Poisson −1.211 0.938 0.969 −0.072 −0.487 2.232 −1.444 0.120 0.005 −0.254
Standard Deviation
Monotone 0.396 0.407 0.124 0.010 0.107 0.792 0.813 0.247 0.020 0.214
GOP 1.230 1.251 0.369 0.029 0.314 0.888 0.957 0.260 0.021 0.236
Poisson 2.077 1.967 0.620 0.033 0.542 1.874 1.739 0.570 0.030 0.482
1st, 2nd, 3rd: the first passenger class, the second passenger class, and the third passenger class. The first class is
chosen as the baseline.
coefficient estimates from our proposed methods and Poisson regression. Coefficient estimates for
logistic regression are not shown as they do not directly describe the dependence of the relative
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Figure 2: Predicted probability of death of the first passenger class (solid line), the second class
(dotted line), and the third class (dashed line) with respect to different models. Red represents
female, and blue represents male.
risk of death on age and sex. The point estimates from our GOP model are close to those from
the Poisson model, while the standard errors are smaller. On the other hand, point estimates for
our Monotone model are different from those given by the other two models. Although it appears
reasonable from the marginal death rates in each passenger class, the monotonic treatment effects
assumption is probably violated after stratifying by age and sex. For example, for males from 25
to 57 years old, the empirical probability of death is 62.8% for the first class , 93.0% for the second
class, and 82.9% for the third class.
Figure 2 displays the fitted probabilities of death from different models. For male passengers in
the second class aged between 30 and 50, the fitted probability of death using the Poisson model
does not lie in the valid range [0, 1]. Under the logistic regression model the fitted probability for
second class females decreases to zero as age approaches 80, whereas this does not happen with
the Generalized Odds Product model. However, in the data set, there were only two females in the
second class who were older than 55 and both of them died. This suggests that our Generalized
Odds Product model may fit the data better. Unlike the other three plots, the fitted lines from the
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Monotone model do not cross each other. This is due to the assumption of monotonic treatment
effects. As we discussed earlier, this assumption may not be plausible for the Titanic data set.
5 Discussion
We have proposed two novel methods to model multiplicative treatment effects with a binary
outcome. The first method relies on a monotonic treatment effect assumption, which can be justified
by appealing to substantive knowledge and checked via exploratory data analysis. For circumstances
where this monotonicity assumption is not appropriate, we propose an alternative approach that
involves a novel generalized odds product model. This approach applies to a categorical treatment
variable, and, in general, requires estimation of a larger number of parameters.
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Abstract
This on-line supplementary file contains proofs of theorems in the main paper, as well as
variance formula for the proposed estimators.
A Proof of Theorem 1
To prove the existence of a unique set of proper probability distributions {pz(v); z ∈ Z, v ∈ V}, it
is sufficient to show that pz(v) can be written as a function of h(z, v) and g(v). Because for any
v ∈ V, h(z, v) is bounded and monotonic in z, limz→zinf h(z, v) and limz→zsup h(z, v) exist, denoted
as h1(v) and h2(v). Without loss of generality, we assume h(z, v) is monotonically non-decreasing
in z. For simplicity, we denote these by limz→zinf pz(v) and limz→zsup pz(v) as pzinf (v) and pzsup(v),
respectively; Let ∆(v) = e2g(v)
(
eh1(v)−h2(v) + 1
)2
+ 4eh1(v)−h2(v)+g(v)
(
1− eg(v)) > 0.
For any fixed v ∈ V, pzsup(v), pzinf (v), pz0(v) and pz(v) via
pzsup(v) =

eg(v){1+eh1(v)−h2(v)}−
√
∆(v)
2eh1(v)−h2(v){eg(v)−1} g(v) 6= 0
1
1+eh1(v)−h2(v) g(v) = 0
, (A.1)
pzinf (v) = pzsup(v)e
h1(v)−h2(v), (A.2)
pz0(v) = pzsup(v)e
−h2(v), (A.3)
pz(v) = pzsup(v)e
h(z,v)−h2(v) (z ∈ Z). (A.4)
We now show
log{rr(z0, z; v)} = h(v, z), (A.5)
log{op(zinf , zsup; v} = g(v). (A.6)
In the case where g(v) = 0, it is easy to see that (A.5) and (A.6) hold. If g(v) 6= 0, for any v ∈ V, one
may divide (A.4) by (A.3) and take the logarithm of both sides. The resulting expression satisfies
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(A.5). Next we prove that pzsup(v) ∈ (0, 1), which is equivalent to showing that pzsup(v){pzsup(v)−
1} < 0 for any fixed v.
pzsup(v){pzsup(v)− 1}
=
[
eg(v){1 + eh1(v)−h2(v)} −√∆(v)] [eg(v) − eh1(v)−h2(v)+g(v) + 2eh1(v)−h2(v) −√∆(v)][
2eh1(v)−h2(v){eg(v) − 1}]2 .
It is enough to prove that the numerator of the above equation is smaller than 0, which can be
directly computed. Further op(zinf , zsup; v) maybe obtained explicitly as:
pzsup(v)pzinf (v)
{1− pzsup(v)}{1− pzinf (v)}
=
{eg(v)(1 + eh1(v)−h2(v))−√∆(v)}2(
eh1(v)−h2(v)+g(v) − 2eh1(v)−h2(v) − eg(v) +√∆(V ))(eg(v) − eh1(v)−h2(v)+g(v) − 2 +√∆(V ))
=
eg(v)
[
2eg(v)
{
eh1(v)−h2(v) + 1
}2 − 4eh1(v)−h2(v){eg(v) − 1} − 2{1 + eh1(v)−h2(v)}√∆(v)]
2eg(v)
{
eh1(v)−h2(v) + 1
}2 − 4eh1(v)−h2(v){eg(v) − 1} − 2{1 + eh1(v)−h2(v)}√∆(v)
= eg(v).
Thus (A.6) is satisfied. This completes our proof.
B Proof of Theorem 2
In order to prove the map given by
(p0(v), . . . , pK(v))→ (logrr(v; 0, 1), . . . , logrr(v; 0,K), loggop(v))
is a diffeomorphism, we need to prove that for any fixed v and any vector (rr(0, 1; v), . . . ,rr(0,K; v),gop(v)) ∈
(R+)K+1, there is one and only one vector (p0(v), . . . , pK(v)) ∈ (0, 1)K+1. Let rr(0, k; v) = ck(v) ∈
R+ where k = 1, . . . ,K, and gop(v) = cK+1(v) ∈ R+. By definition of gop(v), we further have
log{cK+1(v)} = (K+1) log{p0(v)}+
K∑
k=1
log{ck(v)}−log{1−p0(v)}−
K∑
k=1
log{1−p0(v)ck(v)}. (B.1)
In the following, we show that there is one and only one solution of Equation (B.1) for p0(v) ∈
(0, 1). For notational simplicity, write pk(v) as pk, and ck(v) as ck, k = 0, 1, . . . ,K + 1. Let
f(p0) = (K + 1) log p0 +
∑K
k=1 log(ck)− log(1− p0)−
∑K
k=1 log(1− p0ck)− log(cK+1). Now
df(p0)
dp0
=
K + 1
p0
+
1
1− p0 +
K∑
k=1
ck
1− p0ck
=
K + 1
p0
+
1
1− p0 +
K∑
k=1
ck
1− pk > 0.
Therefore f(p0) is monotonically increasing on (0, 1). Because of limp0→0 f(p0) = −∞ and limp0→1 f(p0) =
+∞, there is one and only one root for f(p0) = 0 on (0, 1). Since the domain of M, (R+)K+1, is
the Cartesian product of the marginal domains of the Relative Risk and Generalized Odds Product
2
g β
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θ γ
Figure 3: Variable structure of the proposed method under the monotonic treatment effects as-
sumption.
models, the models in M are variation independent.
C Variance Formula for the Proposed Estimators
C.1 Estimator Assuming Monotonic Treatment Effect
The log-likelihood for a unit can be written as
l(γ, β|z, v, y) = y log{pz(v; γ, β)}+ (1− y) log{1− pz(v; γ, β)}. (C.1)
Without loss of generality, let both the treatment zmin and the baseline treatment be zero. Denote
θ(v) = γTv, g(v) = βTv, ψ(v) = log p0(v), and pz(v) = e
zθ(v)+ψ(v) (z ∈ Z). For simplicity, we write
l, θ, g, ψ, pz, p0 referring to l(γ, β|z, v, y), θ(v), g(v), ψ(v), pz(v), p0(v), respectively. The functional
dependence structure of the variables is shown in Figure 3. Further we have the derivatives of
l(γ, β|zi, vi, yi) with respect to γ and β:
∂l
∂γ
=
∂l
∂pz
(
∂pz
∂θ
∂θ
∂γ
+
∂pz
∂ψ
∂ψ
∂θ
∂θ
∂γ
)
, (C.2)
∂l
∂β
=
∂l
∂pz
∂pz
∂ψ
∂ψ
∂g
∂g
∂β
. (C.3)
In the following, we calculate the terms in (C.2) and (C.3).
∂l
∂pz
=
y − pz
pz(1− pz) ,
∂pz
∂θ
= zpz,
∂pz
∂ψ
= pz.
3
To get ∂ψ∂g ,
∂ψ
∂θ , we start from g(v) = log{op(0, zmax)}.
g = log
p0pzmax
{1− p0}{1− pzmax}
= log
p20e
zmaxθ
(1− p0)(1− p0ezmaxθ)
= 2 log p0 + kθ − log(1− p0)− log(1− p0ezmaxθ)
= 2ψ + zmaxθ − log(1− eψ)− log(1− eψ+zmaxθ).
Because ∂g∂θ = 0, we further have
∂g
∂θ
= 2
∂ψ
∂θ
+ zmax +
eψ ∂ψ∂θ
1− eψ +
eψ+zmaxθ(∂ψ∂θ + zmax)
1− eψ+zmaxθ
= 2
∂ψ
∂θ
+ zmax +
p0
∂ψ
∂θ
1− p0 +
pzmax(
∂ψ
∂θ + zmax)
1− pzmax
= 0.
Therefore, we have
∂ψ
∂θ
= − zmax(1− p0)
1− p0 + 1− pzmax
;
∂g
∂ψ
= 2 +
eψ
1− eψ +
eψ+zmaxθ
1− eψ+zmaxθ
= 2 +
p0
1− p0 +
pzmax
1− pzmax
.
Then
∂ψ
∂g
=
(1− pzmax)(1− p0)
(1− pzmax) + (1− p0)
.
We also have
∂θ
∂γ
= v,
∂g
∂β
= v.
With the above building blocks, we finally have the derivatives:
∂l
∂γ
=
y − pz
1− pz ·
{
z − zmax(1− p0)
(1− p0)(1− pzmax)
}
· v, (C.4)
∂l
∂β
= pz · (1− p0)(1− pzmax)
(1− p0) + (1− pzmax)
· v. (C.5)
The Fisher Information matrix I(α, β) may be calculated to be
I(α, β) = E
[{(
∂l
∂γ
)T
,
(
∂l
∂β
)T}T{( ∂l
∂α
)T
,
(
∂l
∂β
)T}]
= E
( ∂l∂γ)( ∂l∂γ)T ( ∂l∂γ)( ∂l∂β)T(
∂l
∂β
)(
∂l
∂γ
)T (
∂l
∂β
)(
∂l
∂β
)T
 .
Then variance covariance matrix for (γT, βT)T is {nI(γT, βT)}−1, where n is the sample size.
4
C.2 Estimator Assuming a Categorical Treatment
Suppose we observe a unit in treatment arm zk. Denote θk = α
T
kv, , g = β
Tv. Then the first
derivatives of l(α1, . . . , αK , β | z, v, y) with respect to α1, . . . , αK , β are
∂l
∂αj
=
y
pk
∂pk
∂αj
− 1− y
1− pk
∂pk
∂αj
=
y − pk
pk(1− pk)
∂pk
∂αj
(k = 0, 1, . . . ,K; j = 1, . . . ,K), (C.6)
∂l
∂β
=
y − pk
pk(1− pk)
∂pk
∂β
. (C.7)
Since ∂pk/∂αj = ∂(p0e
θk)/∂αj , we further have
∂pk
∂αj
=

∂p0
∂αj
eθk k 6= 0, k 6= j
∂p0
∂αj
eθj + pjx k 6= 0, k = j
∂p0
∂αj
k = 0
; (C.8)
∂pk
∂β
=
∂p0
∂β
eθk . (C.9)
In order to calculate Eq. (C.6) and (C.7), we need to have ∂p0∂αj and
∂p0
∂β . By definition we have
eφ =
∏K
k=0 pk∏K
k=0(1− pk)
.
Taking the logarithm of the both sides gives
φ =
K∑
k=0
log pk −
K∑
k=0
log(1− pk). (C.10)
The derivatives of both sides of (C.10) with respect to αj and β, respectively, are:
0 =
1
p0
∂p0
∂αj
(
K∑
k=0
1
1− pj
)
+
1
1− pj v, (C.11)
v =
1
p0
∂p0
∂β
(
K∑
k=0
1
1− pj
)
. (C.12)
By (C.11) and (C.12), we futher have
∂p0
∂αj
= −
v · −p01−pj∑K
k=0
1
1−pj
, (C.13)
∂p0
∂β
=
p0v∑K
k=0
1
1−pj
. (C.14)
5
Substituting (C.13) and (C.14) into (C.6) to (C.9), we have
∂l
∂αj
=

v(y−pk)
1−pk
− 1
1−pj∑K
l=0
1
1−pl
k 6= 0, k 6= j
v(y−pk)
1−pk
(
1−
1
1−pj∑K
l=0
1
1−pl
)
k 6= 0, k = j
v(y−pk)
1−pk
− 1
1−pj∑K
l=0
1
1−pl
k = 0
,
∂l
∂β
=
(y − pk)v
1− pk
1∑K
l=0
1
1−pl
.
The variance-covariance matrix for (α1, . . . , αK , β) can be calculated as the inverse of the Fisher
Information matrix.
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